These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10669710)

  • 1. Asthma and Cushing's syndrome.
    Wilson AM; Blumsohn A; Jung RT; Lipworth BJ
    Chest; 2000 Feb; 117(2):593-4. PubMed ID: 10669710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
    Harrison TW; Wisniewski A; Honour J; Tattersfield AE
    Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
    Lipworth BJ
    Arch Intern Med; 1999 May; 159(9):941-55. PubMed ID: 10326936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
    Casale TB; Nelson HS; Stricker WE; Raff H; Newman KB
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal suppression with inhaled corticosteroids.
    Lipworth BJ
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):359-61. PubMed ID: 11730176
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenal suppression with cushingoid features from inhaled corticosteroid therapy in an adult asthmatic patient.
    Tsoukas MA; Krishnamoorthy P; Richards BJ; Pepe C; Christopoulos S
    Am J Med; 2014 May; 127(5):e1-2. PubMed ID: 24412770
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ; Clark DJ; McFarlane LC
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
    Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Lönnebo A; Johansson M; Eckernäs SA
    Eur J Clin Pharmacol; 1997; 52(4):261-7. PubMed ID: 9248762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R
    Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.
    Mahlab-Guri K; Asher I; Gradstein S; Zung A; Radian-Sade S; Elbirt D; Sthoeger Z
    J Asthma; 2011 Oct; 48(8):860-3. PubMed ID: 21854345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dull-edged sword of inhaled corticosteroids.
    Harding SM
    Chest; 1999 Oct; 116(4):854-6. PubMed ID: 10531140
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ; Lipworth BJ
    Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate.
    Weiner P; Berar-Yanay N; Davidovich A; Magadle R
    Chest; 1999 Oct; 116(4):931-4. PubMed ID: 10531155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.
    Kamada AK; Szefler SJ; Martin RJ; Boushey HA; Chinchilli VM; Drazen JM; Fish JE; Israel E; Lazarus SC; Lemanske RF
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1739-48. PubMed ID: 8665030
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate.
    Todd G; Dunlop K; McNaboe J; Ryan MF; Carson D; Shields MD
    Lancet; 1996 Jul; 348(9019):27-9. PubMed ID: 8691927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.
    Kannisto S; Korppi M; Remes K; Voutilainen R
    J Clin Endocrinol Metab; 2000 Feb; 85(2):652-7. PubMed ID: 10690871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exogenous Cushing's syndrome as a serious side-effect of therapy with ritonavir an inhaled fluticasone].
    Machala L; Kréze A; Jilich D; Rozsypal H
    Klin Mikrobiol Infekc Lek; 2011 Jun; 17(3):103-5. PubMed ID: 21780031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhaled corticosteroids: first-line therapy in asthma].
    Hajiro T; Ishihara K
    Nihon Rinsho; 2001 Oct; 59(10):1967-72. PubMed ID: 11676140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is fluticasone propionate superior to the other available inhaled steroids?
    Spahn JD
    J Asthma; 1998; 35(4):307-11. PubMed ID: 9669825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.